Search results for "FM"

showing 10 items of 626 documents

First measurement of the W-boson mass in run II of the Tevatron.

2007

7 pages, 4 figures.-- PACS nrs.: 14.70.Fm; 13.38.Be; 13.85.Qk.-- ISI Article Identifier: 000250140600014.-- ArXiv pre-print available at: http://arxiv.org/abs/0707.0085.-- et al.

13.38.Be 14.70.Fm 12.15.Ji 13.85.QkParticle physicsSingle measurementPhysics MultidisciplinaryTevatronFOS: Physical sciencesGeneral Physics and AstronomyElementary particleData recordingddc:500.201 natural sciencesParticle detectorHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)[PACS] Decays of W bosons0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]W-boson massFermilabMeasurement theory010306 general physicsNuclear Experiment[PACS] Hadron-induced inclusive production with identified leptons photons or other nonhadronic particles (energy > 10 GeV)BosonsBosonPhysics010308 nuclear & particles physicsPhysicsHigh Energy Physics::PhenomenologyDetectorsTevatron[PACS] W bosonsHigh Energy Physics::ExperimentBar (unit)
researchProduct

Observation of $Z$ production in proton-lead collisions at LHCb

2014

The first observation of $Z$ boson production in proton-lead collisions at a centre-of-mass energy per proton-nucleon pair of $\sqrt{s_{NN}}=5~\text{TeV}$ is presented. The data sample corresponds to an integrated luminosity of $1.6~\text{nb}^{-1}$ collected with the LHCb detector. The $Z$ candidates are reconstructed from pairs of oppositely charged muons with pseudorapidities between 2.0 and 4.5 and transverse momenta above $20~\text{GeV}/c$. The invariant dimuon mass is restricted to the range $60-120~\text{GeV}/c^2$. The $Z$ production cross-section is measured to be \begin{eqnarray*} ��_{Z\to��^+��^-}(\text{fwd})&=&13.5^{+5.4}_{-4.0}\text{(stat.)}\pm1.2\text{(syst.)}~\text{nb} …

14.70.Hp - Z bosonProtonNuclear Theory01 natural sciencesPhysics Particles & FieldsHigh Energy Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareLuminosityHigh Energy Physics - Experiment (hep-ex)Heavy-ion collision[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Electroweak interaction; Forward physics; Heavy Ions; Heavy-ion collision; Particle and resonance productionElectroweak interactionHeavy IonsHeavy IonNuclear ExperimentQCBosonPhysics25.75.Dw - Relativistic heavy-ion collisions: Particle and resonance production; 14.70.Hp - Z bosons; 13.38.Dg - Decays of Z bosons; 12.15.-y - Electroweak interactionsPhysicsHIGH ENERGIES12.15.-y - Electroweak interactionsParticle physicsComputer Science::Computation and Language (Computational Linguistics and Natural Language and Speech Processing)13.38.Dg - Decays of Z bosons25.75.Dw - Relativistic heavy-ion collisions: Particle and resonance productionPhysical SciencesPARTON DISTRIBUTIONS; BOSON PRODUCTION; HIGH ENERGIES; NUCLEAR PDFS; DEUTERIUM; DECAYFísica nuclearProduction (computer science)14.70.Hp - Z bosonsParticle Physics - ExperimentNuclear and High Energy PhysicsParticle physicsNUCLEAR PDFS530 PhysicsDEUTERIUMFOS: Physical sciencesPhysics InstituteLHCb - Abteilung HofmannHadronsParticle and resonance production0103 physical sciencesElectroweak interaction; Forward physics; Heavy Ions; Heavy-ion collision; Particle and resonance production; Nuclear and High Energy PhysicsSDG 7 - Affordable and Clean Energy010306 general physicsForward physicLarge Hadron Collider (France and Switzerland)BOSON PRODUCTION/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyScience & TechnologyMuon010308 nuclear & particles physicshep-exComputer Science::Information RetrievalGran Col·lisionador d'Hadrons13.38.Dg - Decays of Z bosonPARTON DISTRIBUTIONSForward physicsHigh Energy Physics::ExperimentFísica de partículesExperimentsDECAYEnergy (signal processing)JHEP
researchProduct

Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?

2015

An increasing number of studies using real-time fMRI neurofeedback have demonstrated that successful regulation of neural activity is possible in various brain regions. Since these studies focused on the regulated region(s), little is known about the target-independent mechanisms associated with neurofeedback-guided control of brain activation, i.e. the regulating network. While the specificity of the activation during self-regulation is an important factor, no study has effectively determined the network involved in self-regulation in general. In an effort to detect regions that are responsible for the act of brain regulation, we performed a post-hoc analysis of data involving different ta…

2805 Cognitive NeuroscienceVentrolateral prefrontal cortexBrain regulationCognitive NeuroscienceStress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]610 Medicine & healthCIBM-SPCddc:616.0757Brain mapping050105 experimental psychologyProcedural memory03 medical and health sciences0302 clinical medicineBasal gangliamedicineHumans0501 psychology and cognitive sciencesAnterior cingulate cortexBrain Mapping05 social sciencesBrainCognitionNeurofeedbackMagnetic Resonance Imagingmedicine.anatomical_structureNeurofeedback Real-time fMRI Brain regulationNeurology10054 Clinic for Psychiatry Psychotherapy and Psychosomatics2808 NeurologyMeta-analysisReal-time fMRINeurofeedbackPsychologyNeuroscience030217 neurology & neurosurgeryBrain Regulation ; Neurofeedback ; Real-time FmriNeuroImage
researchProduct

NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DI PATOLOGIE EMATOLOGICHE

2019

La presente invenzione si riferisce al campo di nuove molecole tetracicliche, aventi un sistema tetraciclico, e loro impiego come medicamenti di patologie ematologiche in particolare per il trattamento della leucemia mieloide acuta (AML) in pazienti emizigoti FLT3/ITD resistenti alle terapie convenzionali.

2H-Imidazo [2'1':23][13]thiazolo[45-e]isoindol-8-yl)phenyl]ureas Acute myeloid leukemia (AML) Internal tandem duplication (ITD) FMS-like tyrosine kinase 3 (FLT3) FLT3/ITDSettore CHIM/08 - Chimica Farmaceutica
researchProduct

NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES

2021

2H-Imidazo [2'1':23][13]thiazolo[45-e]isoindol-8-yl-phenylureas Acute myeloid leukemia (AML) Internal tandem duplication (ITD) FMS-like tyrosine kinase 3 (FLT3) FLT3/ITD
researchProduct

3D Image Based Modelling Using Google Earth Imagery for 3D Landscape Modelling

2019

In recent years SfM technique experiments have been innumerable and increasingly refined under metric profiles. The techniques rely on photographic datasets of the objects or landscapes which can require in most cases time consuming and expensive surveys. Recently however there have been increases in the available 3D data of sites worldwide on the Google Earth (GE) platform. This paper presents a unique experimentation that considers integrating readily available datasets from GE and images taken during surveys on ground level for 3D replication without the use of expensive aerial surveys. This will enable practitioners the ability to more easily create 3D models of cultural heritage signif…

3D modelAerial surveyProcess (engineering)Computer scienceGoogle EarthObject (computer science)Data scienceReplication (computing)Cultural heritagePhotogrammetryLandscape modellingPhotogrammetrySfMMetric (mathematics)Reliability (statistics)
researchProduct

Digital Technologies for the Fruition of Archaeological Heritage. The Visualisation of the Temple C Metopes Polychrome in Selinunte

2019

Through the tools of the representation this paper investigates a hypothetical virtual re-presentation of the metopes original polychromies. The reconstructive interpretative process was carried out through a critical reading of historical and iconographic sources. Starting from the reading of drawings made by Angell and Harris at the time of the archaeological finds, of Hittorff’s studies and watercolors, and of some coloured fragments still observable in the original metopes, the graphic elaborations that simulate the original polychromes have been prepared. The purpose of this study and of the analysis here described is the experimentation of an interactive visualisation application (aug…

3D modelmedia_common.quotation_subjectArt history3d modelAugmented realityRepresentation (arts)ArtVideo mappingVisualizationReading (process)Critical readingArchaeological heritageSettore ICAR/17 - DisegnoPolychromeSfM surveymedia_common
researchProduct

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.

2022

Funder: European Commission

ALTtype 2 diabetes mellitusROC receiving operator characteristicaspartate aminotransferaseHSDLDL low-density lipoproteinUHPLC ultrahigh-performance liquid chromatographyROCHCCNon-alcoholic steatohepatitisGCPCANASHGastroenterology2-HB 2-hydroxybutanoic acid; 3-HB 3-hydroxybutanoic acid; ALT alanine aminotransferase; AST aspartate aminotransferase; CE cholesterol ester; Cer ceramide; FFA free fatty acid; FLIP Fatty Liver Inhibition of Progression; Fibrosis; GC gas chromatography; HCC hepatocellular carcinoma; HSD honest significant difference; LC lipid cluster; LDL low-density lipoprotein; LM lipid and metabolite; LMC lipid metabolite and clinical variable; LPC lysophosphatidylcholine; Lipidomics; Mass spectrometry; Metabolomics; NAFL non-alcoholic fatty liver; NAFLD non-alcoholic fatty liver disease; NAS NASH activity score; NASH non-alcoholic steatohepatitis; NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network; NRR non-rejection rate; Non-alcoholic steatohepatitis; PC(O) ether PC; PC phosphatidylcholine; PCA principal component analysis; PE phosphatidylethanolamine; QTOFMS quadrupole-time-of-flight mass spectrometry; ROC receiving operator characteristic; SAF steatosis activity and fibrosis; SM sphingomyelin; T2DM type 2 diabetes mellitus; TG triacylglycerol; UHPLC ultrahigh-performance liquid chromatographySAFSAF steatosis activity and fibrosisLM lipid and metabolitehonest significant differenceHSD honest significant differenceTG triacylglycerolnon-rejection ratecholesterol esterPCPEGC gas chromatographyfree fatty acidFLIPNASH non-alcoholic steatohepatitisNIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkBIOMARKERST2DMPE phosphatidylethanolamineLDLlipidNAFLDFFA free fatty acid2-HBMetabolomicsNAFL non-alcoholic fatty liverLMCphosphatidylcholineScience & TechnologySM sphingomyelinGastroenterology & HepatologyMass spectrometryactivitynutritional and metabolic diseasesT2DM type 2 diabetes mellitusACIDSreceiving operator characteristicdigestive system diseasesquadrupole-time-of-flight mass spectrometryLC lipid clusterlow-density lipoproteinNAS2-HB 2-hydroxybutanoic acidNAS NASH activity scoreQTOFMSether PCNRRSCORING SYSTEMprincipal component analysisgas chromatographyLC2-hydroxybutanoic acidPROGRESSIONAST aspartate aminotransferaseLMPC phosphatidylcholinePC(O)MARKERSUHPLCsteatosisTOOLImmunology and AllergyINSULIN-RESISTANCECerSMFatty Liver Inhibition of Progressionhepatocellular carcinoma2-HB 2-hydroxybutanoic acid NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network NRR non-rejection rate Non-alcoholic steatohepatitis PC(O) ether PC PC phosphatidylcholine PCA principal component analysis PE phosphatidylethanolamine QTOFMS quadrupole-time-of-flight mass spectrometry ROC receiving operator characteristic SAF steatosis activity and fibrosis SM T2DM type 2 diabetes mellitus TG triacylglycerol UHPLC ultrahigh-performance liquid chromatographyultrahigh-performance liquid chromatographyCELPC3-HBNAFLnon-alcoholic fatty liverTGtriacylglycerolNRR non-rejection rateLife Sciences & BiomedicineNAFLD non-alcoholic fatty liver diseaseFLIP Fatty Liver Inhibition of Progressionalanine aminotransferasemetaboliteCer ceramideCE cholesterol estersphingomyelinlysophosphatidylcholineand fibrosisALT alanine aminotransferaseInternal MedicineceramideNational Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkAST3-HB 3-hydroxybutanoic acidQTOFMS quadrupole-time-of-flight mass spectrometryPCA principal component analysisLPC lysophosphatidylcholineHepatologynon-alcoholic fatty liver diseaseand clinical variablePC(O) ether PC3-hydroxybutanoic acidFibrosisNASH activity scoreNIDDK NASH-CRNlipid clusterlipid and metabolitephosphatidylethanolamineLipidomicsLMC lipid metabolite and clinical variableFFAHCC hepatocellular carcinomaJHEP reports : innovation in hepatology
researchProduct

ANALISI DI SICUREZZA DI SISTEMI DELL’IMPIANTO SPES

2014

Il progetto SPES prevede il bombardamento di un bersaglio in carburo di uranio con un fascio di protoni, in modo da generare, tramite reazione nucleare, specie radioattive all’interno del target. Le particelle radioattive generate vengono successivamente estratte, ionizzate, separate in massa ed accelerate come fascio di ioni radioattivo. Il presente lavoro di tesi ha riguardato lo studio di sicurezza di alcune unità dell'impianto SPES e si inserisce nell'ambito di una collaborazione di ricerca tra i Laboratori Nazionali di Legnaro ed il Dipartimento dell'Energia, sezione Nucleare, dell'Università degli Studi di Palermo. Tale attività ha comportato l'analisi sui componenti del sistema di pr…

ANALISI SICUREZZA RELAP5 EXCYTINFNSPESSettore ING-IND/19 - Impianti NucleariFMECA
researchProduct

The 2020 magnetism roadmap

2020

Following the success and relevance of the 2014 and 2017 Magnetism Roadmap articles, this 2020 Magnetism Roadmap edition takes yet another timely look at newly relevant and highly active areas in magnetism research. The overall layout of this article is unchanged, given that it has proved the most appropriate way to convey the most relevant aspects of today's magnetism research in a wide variety of sub-fields to a broad readership. A different group of experts has again been selected for this article, representing both the breadth of new research areas, and the desire to incorporate different voices and viewpoints. The latter is especially relevant for thistype of article, in which one's fi…

Acoustics and UltrasonicsResearch areasComputer science02 engineering and technology01 natural sciences530novel applications of magnetism0103 physical sciencesSelection (linguistics)Relevance (information retrieval)applied magnetism010306 general physicsFELIX Condensed Matter Physics[PHYS]Physics [physics]Field (Bourdieu)500 Naturwissenschaften und Mathematik::530 Physik::530 PhysikNoveltyNovel applications ofmagnetismPhysik (inkl. Astronomie)magnetic phenomena021001 nanoscience & nanotechnologyCondensed Matter PhysicsViewpointsData scienceSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsVariety (cybernetics)Applied magnetism; Magnetic materials; Magnetic phenomena; Novel applications ofmagnetismmagnetic materials0210 nano-technologyYet another
researchProduct